These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11892071)

  • 1. The hyper IgM syndrome.
    Fuleihan RL
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):445-50. PubMed ID: 11892071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper IgM syndrome: the other side of the coin.
    Fuleihan RL
    Curr Opin Pediatr; 2001 Dec; 13(6):528-32. PubMed ID: 11753101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyper IgM syndromes.
    Qamar N; Fuleihan RL
    Clin Rev Allergy Immunol; 2014 Apr; 46(2):120-30. PubMed ID: 23797640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
    Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
    J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome.
    Minegishi Y; Lavoie A; Cunningham-Rundles C; Bédard PM; Hébert J; Côté L; Dan K; Sedlak D; Buckley RH; Fischer A; Durandy A; Conley ME
    Clin Immunol; 2000 Dec; 97(3):203-10. PubMed ID: 11112359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation.
    Durandy A
    Biochem Soc Trans; 2002 Aug; 30(4):815-8. PubMed ID: 12196205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
    Groeneweg M; Lankester AC; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
    Bhushan A; Covey LR
    Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment.
    Ochs HD
    Ann Allergy Asthma Immunol; 2008 May; 100(5):509-11. PubMed ID: 18517086
    [No Abstract]   [Full Text] [Related]  

  • 11. Fevers and mouth ulcers.
    Teo J; Codarini M
    J Paediatr Child Health; 2001 Oct; 37(5):507-9. PubMed ID: 11885719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
    Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
    Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal defects of B lymphocyte differentiation.
    Durandy A
    Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):519-24. PubMed ID: 11964735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
    Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
    Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].
    Groeneweg M; Hartwig NG; Poerink-Stockschläder AB; Schweizer JJ; Bijleveld CM; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1024-8. PubMed ID: 12811975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
    Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
    Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
    J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hyper IgM syndrome--an evolving story.
    Etzioni A; Ochs HD
    Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.
    de Saint Basile G; Tabone MD; Durandy A; Phan F; Fischer A; Le Deist F
    Eur J Immunol; 1999 Jan; 29(1):367-73. PubMed ID: 9933119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.